Cargando…

SETD4 Confers Cancer Stem Cell Chemoresistance in Nonsmall Cell Lung Cancer Patients via the Epigenetic Regulation of Cellular Quiescence

Increasing evidence indicates that quiescent cancer stem cells (CSCs) are a root cause of chemoresistance. SET domain-containing protein 4 (SETD4) epigenetically regulates cell quiescence in breast cancer stem cells (BCSCs), and SETD4-positive BCSCs are chemoradioresistant. However, the role of SETD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yuehong, Yu, Yuman, Yang, Weijun, Wu, Linying, Yang, Yaoshun, Lu, Qianyun, Zhou, Jianying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239305/ https://www.ncbi.nlm.nih.gov/pubmed/37274024 http://dx.doi.org/10.1155/2023/7367854

Ejemplares similares

TROY Modulates Cancer Stem-Like Cell Properties and Gefitinib Resistance Through EMT Signaling in Non–Small Cell Lung Cancer
por: Wu, Linying, et al.
Publicado: (2022)

Regulation of cellular quiescence by YAP/TAZ and Cyclin E1 in colon cancer cells: Implication in chemoresistance and cancer relapse
por: Corvaisier, Matthieu, et al.
Publicado: (2016)

Setd2 regulates quiescence and differentiation of adult hematopoietic stem cells by restricting RNA polymerase II elongation
por: Zhou, Yile, et al.
Publicado: (2018)

Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) combined with bevacizumab for advanced non-squamous non-small-cell lung cancer patients with gradual progression on EGFR-TKI treatment: A cohort study
por: Yu, Yuman, et al.
Publicado: (2021)

The Epigenetic Regulation of Nonhistone Proteins by SETD7: New Targets in Cancer
por: Chiang, Chengyao, et al.
Publicado: (2022)

Bone secreted factors induce cellular quiescence in prostate cancer cells
por: Yu-Lee, Li-Yuan, et al.
Publicado: (2019)

Role of cellular reprogramming and epigenetic dysregulation in acquired chemoresistance in breast cancer
por: Ponnusamy, Logeswari, et al.
Publicado: (2019)

Monitoring Spontaneous Quiescence and Asynchronous Proliferation-Quiescence Decisions in Prostate Cancer Cells
por: Pulianmackal, Ajai J., et al.
Publicado: (2021)

The miR-17-92 cluster counteracts quiescence and chemoresistance in a distinct subpopulation of pancreatic cancer stem cells
por: Cioffi, Michele, et al.
Publicado: (2015)

An IMRT/VMAT Technique for Nonsmall Cell Lung Cancer
por: Zhao, Nan, et al.
Publicado: (2015)

Transcriptional reprogramming in cellular quiescence
por: Roche, Benjamin, et al.
Publicado: (2017)

Histone methyltransferase SETD2: An epigenetic driver in clear cell renal cell carcinoma
por: Yu, Mengxue, et al.
Publicado: (2023)

Autophagy mediates glucose starvation-induced glioblastoma cell quiescence and chemoresistance through coordinating cell metabolism, cell cycle, and survival
por: Wang, Lian, et al.
Publicado: (2018)

SETD2: an epigenetic modifier with tumor suppressor functionality
por: Li, Jun, et al.
Publicado: (2016)

Intra‐heterogeneity in transcription and chemoresistant property of leukemia‐initiating cells in murine Setd2(−/−) acute myeloid leukemia
por: Song, Jiachun, et al.
Publicado: (2021)

Erratum: The miR-17-92 cluster counteracts quiescence and chemoresistance in a distinct subpopulation of pancreatic cancer stem cells
Publicado: (2016)

Personalised medicine for nonsmall cell lung cancer
por: Mascaux, Céline, et al.
Publicado: (2017)

Modern therapies of nonsmall cell lung cancer
por: Jachowski, Andrzej, et al.
Publicado: (2023)

Pemetrexed-associated Ischemic Colitis in Nonsmall Cell Lung Cancer
por: Ye, Liang, et al.
Publicado: (2017)

A New Description of Cellular Quiescence
por: Coller, Hilary A, et al.
Publicado: (2006)

Is There a Histone Code for Cellular Quiescence?
por: Bonitto, Kenya, et al.
Publicado: (2021)

Epigenetic Regulation of RIP3 Suppresses Necroptosis and Increases Resistance to Chemotherapy in NonSmall Cell Lung Cancer
por: Wang, Qiong, et al.
Publicado: (2019)

Crack the state of silence: Tune the depth of cellular quiescence for cancer therapy
por: Fujimaki, Kotaro, et al.
Publicado: (2017)

Small-Molecule Inhibitors of SETD8 with Cellular Activity
por: Blum, Gil, et al.
Publicado: (2014)

TP53 Mutations in Nonsmall Cell Lung Cancer
por: Mogi, Akira, et al.
Publicado: (2011)

Signatures of Drug Sensitivity in Nonsmall Cell Lung Cancer
por: Gong, Hua C., et al.
Publicado: (2011)

The Role of Proteasome Inhibition in Nonsmall Cell Lung Cancer
por: Escobar, Mauricio, et al.
Publicado: (2011)

Gemcitabine for the treatment of advanced nonsmall cell lung cancer
por: Toschi, Luca, et al.
Publicado: (2009)

Thyroid Metastasis from Nonsmall Cell Lung Cancer
por: Namad, Tariq, et al.
Publicado: (2013)

Bronchoscopic treatment of inoperable nonsmall cell lung cancer
por: Kniese, Christopher M., et al.
Publicado: (2020)

Epigenetic Modifier SETD8 as a Therapeutic Target for High-Grade Serous Ovarian Cancer
por: Wada, Miku, et al.
Publicado: (2020)

The PPARγ‐SETD8 axis constitutes an epigenetic, p53‐independent checkpoint on p21‐mediated cellular senescence
por: Shih, Chieh‐Tien, et al.
Publicado: (2017)

Micro‐Topographies Induce Epigenetic Reprogramming and Quiescence in Human Mesenchymal Stem Cells
por: Vermeulen, Steven, et al.
Publicado: (2022)

SETD1A drives stemness by reprogramming the epigenetic landscape in hepatocellular carcinoma stem cells
por: Chen, Jianxu, et al.
Publicado: (2023)

Dormant cancer cells: programmed quiescence, senescence, or both?
por: Truskowski, Kevin, et al.
Publicado: (2023)

Liensinine Inhibits Cell Growth and Blocks Autophagic Flux in Nonsmall-Cell Lung Cancer
por: Chang, Minghui, et al.
Publicado: (2022)

Oligometastatic Disease at Presentation or Recurrence for Nonsmall Cell Lung Cancer
por: Gomez, Daniel R., et al.
Publicado: (2012)

Radiofrequency Ablation for Early-Stage Nonsmall Cell Lung Cancer
por: Hiraki, Takao, et al.
Publicado: (2014)

Pattern of bone metastasis in patients with nonsmall cell lung cancer
por: Miyazaki, Kunihiko, et al.
Publicado: (2018)

Disparate outcomes in nonsmall cell lung cancer by immigration status
por: Chau, Brittney, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b827o6caei80abgb7kusj1bai2